Takeaways From Enforcement Trends In Cannabis Advertising

Law360 (July 31, 2019, 1:21 PM EDT) -- The U.S. Food and Drug Administration’s recent enforcement action against cannabis and CBD producer Curaleaf exemplifies the need for awareness and understanding of the federal and state laws applicable to advertising these heavily regulated products.

The hemp-derived CBD market has been booming following passage of the 2018 Farm Bill which removed hemp-derived CBD (containing less than 0.3% THC) from the Controlled Substances Act. Nevertheless, uncertainty persists around how products containing CBD can be labeled, marketed and advertised. At the forefront in this area is the FDA, which has expedited its consideration of regulations of products containing CBD.

Similarly, in states that...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS